Perspective Therapeutics, Inc. (CATX)
1.17
-0.08
(-6.40%)
USD |
NYAM |
Oct 29, 16:00
1.155
-0.02
(-1.28%)
After-Hours: 20:00
Perspective Therapeutics Market Cap : 133.48M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 133.48M |
| October 28, 2026 | 142.61M |
| October 27, 2026 | 135.76M |
| October 26, 2026 | 138.04M |
| October 23, 2026 | 183.68M |
| October 22, 2026 | 257.83M |
| October 21, 2026 | 262.40M |
| October 20, 2026 | 262.40M |
| October 19, 2026 | 249.85M |
| October 16, 2026 | 247.57M |
| October 15, 2026 | 266.96M |
| October 14, 2026 | 255.55M |
| October 13, 2026 | 258.98M |
| October 12, 2026 | 287.50M |
| October 09, 2026 | 303.47M |
| October 08, 2026 | 309.17M |
| October 07, 2026 | 280.65M |
| October 06, 2026 | 269.24M |
| October 05, 2026 | 293.20M |
| October 02, 2026 | 314.88M |
| October 01, 2026 | 310.31M |
| September 30, 2026 | 313.74M |
| September 29, 2026 | 298.91M |
| September 28, 2026 | 285.22M |
| September 25, 2026 | 287.50M |
| Date | Value |
|---|---|
| September 24, 2026 | 285.22M |
| September 23, 2026 | 298.91M |
| September 22, 2026 | 337.69M |
| September 21, 2026 | 338.84M |
| September 18, 2026 | 328.57M |
| September 17, 2026 | 328.57M |
| September 16, 2026 | 308.03M |
| September 15, 2026 | 311.46M |
| September 14, 2026 | 333.13M |
| September 11, 2026 | 320.58M |
| September 10, 2026 | 316.02M |
| September 09, 2026 | 341.12M |
| September 08, 2026 | 355.95M |
| September 04, 2026 | 357.09M |
| September 03, 2026 | 355.95M |
| September 02, 2026 | 353.67M |
| September 01, 2026 | 353.67M |
| August 31, 2026 | 360.51M |
| August 28, 2026 | 354.81M |
| August 27, 2026 | 362.79M |
| August 26, 2026 | 360.51M |
| August 25, 2026 | 375.34M |
| August 24, 2026 | 363.93M |
| August 21, 2026 | 376.48M |
| August 20, 2026 | 366.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 291.62M |
| MiMedx Group, Inc. | 578.53M |
| ABVC BioPharma, Inc. | 26.80M |
| Enovis Corp. | 1.315B |
| Edwards Lifesciences Corp. | 54.45B |
Market Cap Related Metrics
| PS Ratio | 266.67 |
| PEG Ratio | -2.118 |
| Price to Book Value | 0.4122 |
| Price | 1.17 |
| Earnings Yield | -113.6% |
| PEGY Ratio | -2.118 |